Coffee with Suzy : Episode 19

Podcast

Pharmacist Moms: Coffee With Suzy - Episode 19

Suzanne Soliman, PharmD, BCMAS welcomes Sonia T. Oskouei, PharmD, BCMAS, DPLA to discuss biosimilars within the pharmacy industry.

On this week’s highly anticipated episode, Suzanne Soliman, PharmD, BCMAS, welcomes Sonia T. Oskouei, PharmD, BCMAS, DPLA, to discuss biosimilars within the pharmacy industry. Listen now to hear from Sonia about how she got to where she is today, being an inspiring leader in the biosimilars industry. You will not want to miss it!

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Related Content
Childers Queensland Australia - April 21 2024: Mounjaro tirzepatide GLP-1 GIP receptor agonist, injection injectable type 2 diabetes, off label weight loss, PBS restrictions Australia, drug medication - Image credit: Cynthia | stock.adobe.com
June 23rd 2025

ADA 2025: Advances in Type 2 Diabetes Management With Tirzepatide

Kennedy Ferruggia, Assistant Editor
Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care
June 17th 2025

Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
UACR test for chronic kidney disease (CKD) -- Image credit: MdBabul | stock.adobe.com
June 23rd 2025

Lorundrostat Shows Clinically Meaningful Outcomes in Patients With CKD and Hypertension

Gillian McGovern, Associate Editor
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
June 3rd 2025

S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk

Alexandra Gerlach, Associate Editor
Close-up image of Semaglutide pens for glucose and weight management Image credit: Edugrafo | stock.adobe.com
June 22nd 2025

ADA 2025: CagriSema Demonstrates Significant Weight Loss in REDEFINE Clinical Trials

Kennedy Ferruggia, Assistant Editor
Diabetes Complications: Unveiling the Health Risks and Long - Term Consequences - Image credit: 波 刘 | stock.adobe.com
June 22nd 2025

ADA 2025: Semaglutide Shows Promise in Improving Mobility for Patients With Diabetes and Peripheral Arterial Disease

Kennedy Ferruggia, Assistant Editor